Complement is the group of serum glycoprotein, the part of innate immune system that enhances the ability of antibodies and macrophages to clear the damaged cells and pathogens. Complement also promotes inflammation and aids in enhancing the immune response. The complement system is activated through a cascade. Complement deficiency is a primary immunodeficiency disorder. Deficiency in any component of complement can lead to immunosuppression, infections and sepsis. Clinical indication for complement deficiency include bacterial infection, autoimmune disease or episodes of angioedema. The deficiency can be either inherited or acquired, also it can be either complete or partial. One can screen the complement deficiency using different diagnosis test such as by performing the total serum complement classic hemolytic complement test or alternative hemolytic complement test.
The global Complement Deficiency Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Rise in prevalence of chronic diseases such as kidney disease, serum sickness may be one of the factor resulting in rise of the global complement deficiency test market. Rise in the rate of common variable immunodeficiency disease, rise in recurrent microbial infection such as Streptococcus pneumoniae, Neisseria meningitides, and Neisseria gonorrhea are the key factors likely to propel the growth of the global complement deficiency test market through 2024. High cost of therapies and lack of proper reimbursement are the few of the factors that are likely to hamper the growth of the global complement deficiency market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Complement Deficiency Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Deficiency Tests.
Report Scope
The Complement Deficiency Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Complement Deficiency Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement Deficiency Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Wako Diagnostics
Kypha
Beckman Coulter
Thermo Fisher Scientific
Abbiotec
Acris Antibodies
Linscott's
Assaypro
Segment by Type
Serological And Immunological Assay
Molecular Diagnostic Tests
Immunohistochemistry Techniques
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Deficiency Tests companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Complement Deficiency Tests 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Serological And Immunological Assay
1.2.3 Molecular Diagnostic Tests
1.2.4 Immunohistochemistry Techniques
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Complement Deficiency Tests 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complement Deficiency Tests 麻豆原创 Perspective (2019-2030)
2.2 Complement Deficiency Tests Growth Trends by Region
2.2.1 Global Complement Deficiency Tests 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Complement Deficiency Tests Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Complement Deficiency Tests Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Complement Deficiency Tests 麻豆原创 Dynamics
2.3.1 Complement Deficiency Tests Industry Trends
2.3.2 Complement Deficiency Tests 麻豆原创 Drivers
2.3.3 Complement Deficiency Tests 麻豆原创 Challenges
2.3.4 Complement Deficiency Tests 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complement Deficiency Tests Players by Revenue
3.1.1 Global Top Complement Deficiency Tests Players by Revenue (2019-2024)
3.1.2 Global Complement Deficiency Tests Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Complement Deficiency Tests 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Complement Deficiency Tests Revenue
3.4 Global Complement Deficiency Tests 麻豆原创 Concentration Ratio
3.4.1 Global Complement Deficiency Tests 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement Deficiency Tests Revenue in 2023
3.5 Complement Deficiency Tests Key Players Head office and Area Served
3.6 Key Players Complement Deficiency Tests Product Solution and Service
3.7 Date of Enter into Complement Deficiency Tests 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Deficiency Tests Breakdown Data by Type
4.1 Global Complement Deficiency Tests Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Complement Deficiency Tests Forecasted 麻豆原创 Size by Type (2025-2030)
5 Complement Deficiency Tests Breakdown Data by Application
5.1 Global Complement Deficiency Tests Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Complement Deficiency Tests Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Complement Deficiency Tests 麻豆原创 Size (2019-2030)
6.2 North America Complement Deficiency Tests 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Complement Deficiency Tests 麻豆原创 Size by Country (2019-2024)
6.4 North America Complement Deficiency Tests 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Complement Deficiency Tests 麻豆原创 Size (2019-2030)
7.2 Europe Complement Deficiency Tests 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Complement Deficiency Tests 麻豆原创 Size by Country (2019-2024)
7.4 Europe Complement Deficiency Tests 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complement Deficiency Tests 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Complement Deficiency Tests 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Complement Deficiency Tests 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Complement Deficiency Tests 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Complement Deficiency Tests 麻豆原创 Size (2019-2030)
9.2 Latin America Complement Deficiency Tests 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Complement Deficiency Tests 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Complement Deficiency Tests 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complement Deficiency Tests 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Complement Deficiency Tests 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Complement Deficiency Tests 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Complement Deficiency Tests 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wako Diagnostics
11.1.1 Wako Diagnostics Company Detail
11.1.2 Wako Diagnostics Business Overview
11.1.3 Wako Diagnostics Complement Deficiency Tests Introduction
11.1.4 Wako Diagnostics Revenue in Complement Deficiency Tests Business (2019-2024)
11.1.5 Wako Diagnostics Recent Development
11.2 Kypha
11.2.1 Kypha Company Detail
11.2.2 Kypha Business Overview
11.2.3 Kypha Complement Deficiency Tests Introduction
11.2.4 Kypha Revenue in Complement Deficiency Tests Business (2019-2024)
11.2.5 Kypha Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Detail
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Complement Deficiency Tests Introduction
11.3.4 Beckman Coulter Revenue in Complement Deficiency Tests Business (2019-2024)
11.3.5 Beckman Coulter Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Complement Deficiency Tests Introduction
11.4.4 Thermo Fisher Scientific Revenue in Complement Deficiency Tests Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Abbiotec
11.5.1 Abbiotec Company Detail
11.5.2 Abbiotec Business Overview
11.5.3 Abbiotec Complement Deficiency Tests Introduction
11.5.4 Abbiotec Revenue in Complement Deficiency Tests Business (2019-2024)
11.5.5 Abbiotec Recent Development
11.6 Acris Antibodies
11.6.1 Acris Antibodies Company Detail
11.6.2 Acris Antibodies Business Overview
11.6.3 Acris Antibodies Complement Deficiency Tests Introduction
11.6.4 Acris Antibodies Revenue in Complement Deficiency Tests Business (2019-2024)
11.6.5 Acris Antibodies Recent Development
11.7 Linscott's
11.7.1 Linscott's Company Detail
11.7.2 Linscott's Business Overview
11.7.3 Linscott's Complement Deficiency Tests Introduction
11.7.4 Linscott's Revenue in Complement Deficiency Tests Business (2019-2024)
11.7.5 Linscott's Recent Development
11.8 Assaypro
11.8.1 Assaypro Company Detail
11.8.2 Assaypro Business Overview
11.8.3 Assaypro Complement Deficiency Tests Introduction
11.8.4 Assaypro Revenue in Complement Deficiency Tests Business (2019-2024)
11.8.5 Assaypro Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Wako Diagnostics
Kypha
Beckman Coulter
Thermo Fisher Scientific
Abbiotec
Acris Antibodies
Linscott's
Assaypro
听
听
*If Applicable.
